Newsroom
Latest News
News
Sera To Present At Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit
September 13, 2021- Sera will present at the Oppenheimer Fall Healthcare Life Sciences & Med Tech Summit on Tuesday, September 21, 2021 at 8:15 a.m. Eastern Time.
News
Sera Reports Second Quarter 2021 Financial Results
August 30, 2021- Sera announced financial results for the second quarter ended June 30, 2021.
News
Sera’ PreTRM® Test and Treat Strategy Benefits Demonstrated by Results of Prospective, Randomized Controlled Intervention Trial Evaluating Clinical Utility
August 17, 2021- Study demonstrates positive impact of the company’s PreTRM® test and treat strategy on improving neonatal healthcare
News
Sera Announces Pricing of Initial Public Offering
July 14, 2021 – Sera today announced the pricing of its initial public offering of 4,687,500 shares of its common stock at a price to the public of $16.00 per share.
News
Sera and Anthem, Inc. Announce Commercial Partnership Leveraging Innovative Biomarker Test to Reduce Risk of Preterm Birth
May 19, 2021-The PreTRM® Test Is Designed to Build a Foundation for Healthy Communities One Baby at a Time
News
Evaluation Of Health And Economic Benefit Of The PreTRM® Test-and-treat Strategy To Improve Maternal And Infant Health Among Commercially Insured In The Us
May 18, 2021-Data presented at the ISPOR 2021 Conference illustrating clinical benefit as well as cost savings
News
Sera Completes $100 Million Series E Financing
April 28, 2021-Several prominent healthcare-focused institutional investors fund Sera to expand commercialization of the PreTRM® Test.
News
Sera Appoints Benjamin G. Jackson as General Counsel
April 13, 2021-Highly accomplished attorney joins Sera to develop its legal and intellectual property functions.
News
Sera Appoints Robert G. Harrison As Chief Information Officer
March 31, 2021- Accomplished technology leader joins Sera to build and deploy its information strategy.
News
American Medical Association (AMA) Grants Sera A Cpt® Pla Code For PreTRM®, The Only Broadly Validated Blood Test To Assess Risk Of Preterm Birth
February 3, 2021- Receipt of dedicated CPT® code marks important commercialization milestone to pursue reimbursement for the PreTRM® Test.